Kenneth Cusi Selected Research

Kenneth Cusi Research Topics

Disease

76	Non-alcoholic Fatty Liver Disease 01/2024 - 11/2006
53	Type 2 Diabetes Mellitus (MODY) 12/2023 - 02/2002
52	Insulin Resistance 01/2024 - 06/2002
30	Fibrosis (Cirrhosis) 01/2024 - 11/2006
15	Fatty Liver 01/2024 - 09/2007
14	Alcoholic Fatty Liver 10/2023 - 09/2007
14	Inflammation (Inflammations) 11/2021 - 11/2006
12	Liver Diseases (Liver Disease) 11/2023 - 01/2013
12	Obesity 01/2023 - 09/2004
9	Weight Loss (Weight Reduction) 05/2022 - 04/2012
8	Prediabetic State (Prediabetes) 03/2019 - 04/2012
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2016
7	Body Weight (Weight, Body) 03/2022 - 08/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 09/2007
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 09/2007
5	Hypoglycemia (Reactive Hypoglycemia) 07/2023 - 07/2017
5	Weight Gain 07/2023 - 10/2007
4	Overweight 12/2021 - 12/2006
4	Glucose Intolerance 10/2009 - 08/2006
3	Disease Progression 07/2023 - 01/2019
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 07/2017
3	Dyslipidemias (Dyslipidemia) 10/2021 - 01/2010
3	Neoplasms (Cancer) 01/2021 - 08/2017
3	Edema (Dropsy) 01/2020 - 08/2006
2	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 06/2022
2	Hypertension (High Blood Pressure) 01/2023 - 01/2019
2	Hyperglycemia 06/2022 - 10/2003
2	Heart Failure 03/2022 - 01/2022
2	Necrosis 01/2019 - 11/2006
2	Hypertriglyceridemia 01/2017 - 04/2016
2	Hyperinsulinism (Hyperinsulinemia) 04/2016 - 06/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 03/2008
2	Hyperemia 01/2008 - 12/2006
1	Infections 07/2023
1	Diabetes Mellitus 07/2023
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023
1	Morbid Obesity 11/2022

Drug/Important Bio-Agent (IBA)

50	Insulin (Novolin)FDA Link 07/2023 - 02/2002
39	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 02/2002
33	Pioglitazone (Actos)FDA Link 01/2024 - 06/2002
26	Triglycerides (Triacylglycerol)IBA 01/2023 - 07/2003
20	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 08/2002
12	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024 - 01/2018
12	LipidsIBA 01/2023 - 10/2003
11	Alanine Transaminase (SGPT)IBA 01/2023 - 11/2006
11	Transaminases (Aminotransferases)IBA 01/2023 - 11/2006
8	Hemoglobins (Hemoglobin)IBA 03/2022 - 08/2006
7	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 11/2006
6	AdiponectinIBA 01/2023 - 09/2004
5	Vitamin E FDA LinkGeneric 01/2022 - 04/2012
5	Protons (Proton)IBA 01/2019 - 01/2015
5	HDL CholesterolIBA 01/2017 - 02/2010
4	Sodium-Glucose Transport ProteinsIBA 01/2024 - 10/2020
4	Keratin-18 (Keratin 18)IBA 01/2023 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 09/2007
4	2,4-thiazolidinedione (thiazolidinedione)IBA 06/2013 - 11/2006
4	ThiazolidinedionesIBA 06/2013 - 08/2006
3	SodiumIBA 07/2023 - 01/2019
3	nasIBA 01/2023 - 01/2018
3	EnzymesIBA 10/2022 - 07/2003
3	HDL LipoproteinsIBA 06/2022 - 02/2016
3	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2022 - 01/2022
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2021 - 01/2021
3	PPAR gammaIBA 03/2008 - 03/2005
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 10/2020
2	2- chloro- 3- (1- hydroxy- 5,6,7,8- tetrahydronaphthalen- 2- yl)- 6- oxo- 5- phenyl- 7H- thieno)(2,3- b)pyridin- 4- olate potassiumIBA 12/2021 - 11/2021
2	Adenylate KinaseIBA 12/2021 - 11/2021
2	Testosterone (Sustanon)FDA Link 01/2021 - 08/2006
2	semaglutideIBA 01/2021 - 10/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2020 - 07/2017
2	Complement C3 (C3 Complement)IBA 01/2020 - 01/2019
2	AdipokinesIBA 01/2019 - 09/2004
2	IncretinsIBA 01/2019 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 04/2012
2	Blood Glucose (Blood Sugar)IBA 12/2016 - 10/2011
2	Tricarboxylic AcidsIBA 04/2016 - 08/2015
2	ApolipoproteinsIBA 02/2016 - 01/2010
2	Lipoproteins (Lipoprotein)IBA 02/2016 - 02/2010
2	Fenofibrate (CiL)FDA LinkGeneric 02/2010 - 09/2007
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2008 - 12/2006
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2008 - 12/2006
2	acipimoxIBA 06/2007 - 09/2004
2	GlycogenIBA 07/2003 - 02/2002
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2023
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2023
1	prednylidene (Pred)IBA 01/2023
1	lipoprotein cholesterolIBA 01/2023
1	SolutionsIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Phospholipases (Phospholipase)IBA 10/2022
1	very low density lipoprotein triglycerideIBA 10/2022

Therapy/Procedure

20	Therapeutics 01/2024 - 02/2002
5	Liver Transplantation 11/2023 - 01/2019
5	Glycemic Control 11/2021 - 11/2006
4	Bariatric Surgery 01/2023 - 01/2020
3	Injections 11/2021 - 01/2008
2	Organ Transplantation 12/2023 - 07/2023
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2023
1	Precision Medicine 01/2023